Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-14

FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lisinopril from Actavis Pharma, Inc., authorizing the marketing of a generic lisinopril product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)